Intermittent claudication is a relative indication for vascular reconstruction. Conservative management with a combination of risk factor control, exercise training and medical therapy will relieve or at least improve claudication in some patients. If claudication precludes gainful employment or imposes an unacceptable alteration in lifestyle, surgical revascularization should be considered. Surgical bypass for claudication will produce optimal results in younger patients, in whom near-normalization of the ankle/brachial index can be anticipated. Proximal axial (in-line) reconstructions maintain their patencies longer than more distal, and often technically more challenging, bypasses. These tenets also apply well to percutaneous transluminal angioplasty. Both surgical and catheter-based interventions carry potential risks of short-and long-term morbidity, although overall morbidity associated with surgery for claudication is acceptably low. Interventions are justified only if they are safe, effective and durable, and if they are performed after the long-term prognosis for both life and limb is considered.
Introduction
The contemporary approach to patients with claudication caused by short segmental arterial occlusive disease includes the use of exercise training and various endovascular procedures, including percutaneous transluminal angioplasty (PTLA) and surgery (bypass or endarterectomy). The optimal treatment in terms of patient risk, benefit and cost has not been established and remains controversial.
Surgical treatment
Surgical revascularization should be considered in patients with claudication that precludes gainful employment or imposes an unacceptable alteration in lifestyle, if medical therapy has been ineffective. Because the determination of disability resulting from functional limb ischemia is highly subjective, it is initially the patient's prerogative to request revascularization, provided he or she understands the risk of surgery and the anticipated benefits of a more conservative, nonsurgical approach. As the severity of the claudication increases, it becomes the surgeon's responsibility to select the procedure that will improve the circulation most effectively, taking into consideration the patient's risk status and the prevailing pattern of vascular disease. Surgical bypass produces optimal results in younger patients with claudication, in whom near-normalization of the ankle/brachial index (ABI) can be anticipated. Proximal axial (in-line) reconstructions maintain their patencies longer than more Department of Surgery. Section of Vascular Surgery. University of Colorado Health Sciences Center. Denver. CO. USA
Indications for surgery
Indications for surgical revascularization in patients with lower extremity ischemia have been defined in terms of severity of symptoms, Data from noninvasive hemodynamic laboratory tests serve to corroborate the diagnosis but are not used as the singular indication for surgery. There is general agreement that surgical treatment is indicated to relieve symptoms of limb-threatening ischemia, including pain at rest, ischemic ulcers and gangrene, J and surgery is indicated to remove or to bypass and exclude sources of atheroernboli.' In contrast, intermittent claudication is often considered to be only a relative indication for vascular reconstruction, and then only after an adequate trial of nonsurgical therapy. Numerous reports documenting the benign natural history of intermittent claudication have formed the basis for the conservative approach that is usually followed. Nonetheless, aortofemoral reconstruction is routinely used to treat claudication because of both the excellent long-term patency rates achievable and the perception that claudication in patients with aortoiliac disease may progress to critical ischemia, Although more controversial, a role for femoropopliteal bypass grafting in patients with severe claudication is supported by the low operative risk and the excellent long-term results obtained in contemporary series. Interestingly, patients are often offered bypass surgery early if their ABI is unexpectedly low, their symptoms have worsened precipitously, or their claudication distance is unacceptably short. This decision is predicated on the fear that claudication in these patients will rapidly progress to either rest pain or gangrene. There is no consensus regarding the severity of disease, whether assessed by symptoms or by hemodynamic parameters, for which surgical treatment of claudication is uniformly appropriate.
The results of treatment of claudication are typically evaluated according to multiple parameters, which have been summarized in the recommended reporting standards of the Joint Vascular Societies.' These parameters include the morbidity and mortality associated with the surgery and the patency of the surgical repair. Patency is best defined in hemodynamic terms such as a sustained improvement in ABI ($15% variance) or by other objective means (postoperative angiography or duplex scanning). Patency is classified as primary or secondary. Primary patency refers to uninterrupted patency of the original treatment without any revision such as thrombectomy, thrombolytic infusion or angioplasty; secondary patency refers to patency of the repair as maintained by these measures. Primary patency describes the success of the procedure itself. whereas secondary patency describes the success of the procedure and its postoperative follow-up to include the detection and treatment of complications. Comparison of various surgical procedures requires the use of primary patency figures. In addition to patency, other parameters for evaluating surgical procedures on the lower extremity to relieve symptoms of limb-threatening ischemia are limb salvage, defined as retention of the limb without the need for amputation above the metatarsal level, and long-term patient survival. Patency, limb salvage and patient survival are calculated and represented using the life-table method. 1 These objective parameters are clearly well suited to evaluating the quantitative outcome of surgical treatment. However, many other parameters may be as appropriate as, or more appropriate than, patency, limb salvage or survival in determining the success of surgery in patients with claudication. Adequate relief of symptoms -including relief of pain -healing of ischemic lesions, return to unimpeded ambulation, maintenance of independent living, and general level of patient satisfaction or quality of life are all valid parameters for assessment of lower extremity revascularization, especially from the patient's point of view. Few, if any, of these parameters are addressed in most modem series, but they are likely to become increasingly important in future investigations." This is particularly true in the treatment of claudication, the primary goal of which is to relieve claudication symptoms and improve functional status.
Surgical therapy (bypass or endarterectomy) is traditionally reserved for severe disabling claudication or limbthreatening ischemia and carries a 5-year overall patency rate of 57-72%.~Results of surgery have not been analyzed in large numbers of patients with isolated femoropopliteal lesions and moderately stable claudication. According to the results of large series, patients with claudication and good distal runoff generally have better results than those who have more advanced occlusive disease, with 5-year patency rates as high as 82% and operative mortality rates <3%.6.7 Advocates of surgery point out that patients treated with surgery have much better overall long-term results than those treated with percutaneous techniques and that the morbidity and mortality rates associated with surgery have steadily been reduced. Surgical bypass is also associated with a higher initial success rate than other treatments, a benefit that is clearly maintained at follow-up.
Surgery compared with other treatment options
No prospective randomized studies of adequate size and trial design have compared surgical treatment of lower extremity c1audicative ischemia with other therapies. In Vascular Medicine 1997; 2: 252-256
Role of revascularization in the treatment of claudication 253 studies comparing various therapies for claudication, no apparent difference in outcome has been found. 1 Surgical treatment of intermittent claudication was compared with exercise therapy in 1989 by Lundgren et a1. 8 These authors randomly assigned 75 patients with intermittent claudication verified by vascular laboratory testing to one of three treatment groups: surgical bypass alone, surgery combined with exercise training, or exercise training alone. Patients in each group did not differ as to risk factors and disease severity. The ABIs and toe blood pressures increased significantly in the two groups that underwent surgery but not in the group that received exercise training alone. Calf muscle blood flow and walking performance improved significantly in all three groups, with the surgeryplus-exercise group showing significantly greater improvement than the surgery-alone group and the surgery-alone group showing greater improvement than the exercise-alone group. As expected, the surgical groups experienced more complications than the exercise-alone group.
A comparison of surgical reconstruction and PTLA for treatment of lower extremity ischemia was examined in the Veterans Administration Cooperative Study No. 199. the results of which were reported by Wilson et al in 1989. 9 A total of 263 men from seven VA hospitals were randomly assigned to treatment with surgery or balloon angioplasty. To be eligible for this study. patients had to have angiographic lesions that both surgical and radiological investigators agreed were appropriate for angioplasty. Although symptom severity was not a limiting factor, in most patients disease was less severe than that usually treated with surgery: 73% had claudication only and the remainder had ischemic pain at rest. No patients had ischemic ulcers or gangrene. The groups were well matched with respect to symptoms, risk factors, and severity and location of disease as assessed by both angiography and hemodynamics. The parameters evaluated included treatment failure (defined as a loss of patency or failure to achieve initial improvement as determined by objective criteria) and patient survival. The surgical group maintained higher success rates in each category (p = 0.037), with the differences being explained almost entirely by the lower initial success rate of angioplasty. In this study, successful angioplasty was as durable as successful bypass surgery. However, this trial has been criticized because the surgical results may have been compromised by the inclusion of prosthetically grafted patients in the infrainguinal bypass group. I Although numerous publications have described the overall results of lower extremity surgical revascularizarion. it is relatively difficult to analyze the results because the many usual factors that influence outcome of the surgical procedures were largely ignored. These included the indication for operation (claudication or limb-threatening ischemia), the surgical site (aortoiliac, infrainguinal or multilevel) and whether the operation was performed for primary or secondary revascularization, For infrainguinal bypass operations, the bypass conduit material (greater saphenous vein. alternative vein or prosthesis) and the site of the distal anastomosis (popliteal. tibial or pedal) are also important. In patients with aortoiliac disease, the presence or absence of simultaneous femoropopliteal disease influences results, as does the procedure performed (anatomic or axial bypass. extra-anatomic bypass or endarterectomy). As mentioned, few of these studies describe the outcomes of the surgical procedure in terms of symptom relief and improvement in exercise performance and overall functional status. Unless patients are stratified for each of these factors and appropriate outcomes measured, it is impossible to draw complete and meaningful conclusions from the results of studies of the surgical treatment of lower extremity claudicative ischemia.
As a review of the literature shows, the range of anticipated results of revascularization is wide, depending on the variables described above. Understanding these relationships is critical if meaningful comparison of the results of various techniques is to be made. It is quite inappropriate to compare the results of PTLA performed to treat claudication with the results of surgery that include many patients who undergo surgery for limb salvage. Similarly, it is inappropriate to compare the results of prosthetic bypass performed preferentially in patients with claudication in whom venous bypass would have been possible with the results of prosthetic bypass performed after all possible sources of autogenous vein were exhausted. This approach emphasizes the importance of randomized trials for meaningful comparison of surgical and nonsurgical techniques. It also emphasizes the importance of rigid adherence to recommended standards for all reports describing treatment of lower extremity ischemia, regardless of whether treatment is surgical or nonsurgical. I Survival rates for lower extremity revascularization vary widely, depending on the specific patient population. Markedly reduced survival is seen among these patients compared with the anticipated survival among those in the general population without specific manifestations of atherosclerosis. Several reports have suggested that longterm survival is directly correlated with the severity of the presenting lower extremity ischemia, whether assessed by symptomatology, physiological tests or the extent of anatomic lesions,u},-'2 For example, the 5-year survival rate among patients with claudication treated nonoperatively has been reported to be as high as 87%, IJ compared with 80% among patients with claudication treated with surgery;" 38% among patients undergoing surgery for limb-threatening ischemia" and only 12% among patients undergoing re-operative surgery for limb-threatening ischemia. I" These statistics emphasize the need for a comprehensive evaluation and ongoing treatment of patients with peripheral arterial occlusive disease. The high cardiovascular mortality rates point to the need for aggressive risk factor modification and the use of antiplatelet drugs to alter the natural history of this disease process.
Percutaneous transluminal angioplasty
In recent years, the use of interventional radiological procedures for the treatment of acute and chronic lower extremity arterial disease has increased dramatically. This increase reflects the advances in vascular imaging and intervention that have made PTLA safer and more feasible. These advances include the development of intravascular stents and the widespread use of intra-arterial thrombolysis for the treatment of peripheral arterial thrombosis. Some physicians, particularly interventional radiologists, now advocate PTLA as the preferred therapy for claudication in patients with discrete aortoiliac or superficial femoral artery Vascular Medicine 1997; 2: 252-256 occlusive disease. Reports of this approach claim a complication rate of <5%, a technical success rate of 72-97%, and 1to 3-year patency rates from 73% to 90%. [17] [18] [19] [20] [21] [22] It is claimed that the patency of PTLA rivals that of operative bypass, while the associated morbidity and morality rates are decidedly lower in the interventional groups. However, the functional performance benefits of PTLA have not yet been established.
The majority of patients with symptomatic aortoiliac disease do not require an invasive intervention. For those with incapacitating claudication or limb-threatening ischemia, angioplasty and lower extremity bypass surgery are the two major therapeutic options. Percutaneous transluminal angioplasty is an appropriate choice only when two important criteria are met: (l) disease is confined to the common iliac artery and affects a segment < 10 em long; and (2) an experienced interventionalist is available." Data comparing surgery with PTLA in patients with lower extremity arterial disease are limited. In one randomized study that included 252 patients, there was no difference in clinical outcomes during a mean follow-up of 4 years." Even when the influence of site (iliac versus femoropopliteal) and indication (limb salvage versus claudication) was examined, no difference in outcome was found. However, about one-third of patients randomly assigned to PTLA required at least one additional vascular procedure during the study period, which increased the overall cost of this arm of the treatment protocol.
Noncontrolled case series reports suggest that PTLA of the iliac arteries is associated with better long-term success rates than more distal angioplasty." Iliac PTLA is useful not only for dilatation of primary lesions but also as an adjunct to definitive femoropopliteal surgery, for which success rates are high when the procedure is carefully performed." In this series, the extent of disease at presentation influenced the long-term patency rates and the complication rate was relatively low at 4%.
Noncontrolled case series reports confirm that PTLA in the femoropopliteal region is associated with a higher risk of failure than iliac PTLA. 27 Factors that adversely affect long-term patency include diabetes mellitus, diffuse atherosclerosis, limb-threatening ischemia, long or eccentric lesions, and poor initial post-PTLA appearance. A recent decision analysis evaluating the cost-effectiveness of revascularization procedures for femoropopliteal disease suggests that PTLA is the preferred initial treatment in patients with disabling claudication. In those with critical leg ischemia, PTLA was more effective for the treatment of femoropopliteal stenosis, whereas femoropopliteal occlusion was best managed with bypass grafting (Figure  1 ).21<
The adjunctive use of vascular stents has been suggested to provide more durable vascular dilatation than simple PTLA, particularly when the patient is at high risk for restenosis." Currently available intravascular stents are either balloon expandable (e.g. the Palmaz and Strecker stents) or self-expandable (e.g. the Wallstent and Gianturco stents). Although stents appear to be useful for management of PTLA-induced dissections.P-" their roles in primary infrainguinal PTLA have not been established. Surgical revascularization to relieve the symptoms of claudication has comprised a significant proportion of surgical procedures performed in patients with peripheral arterial occlusive disease. This proportion is declining as noninvasive medical treatments gain greater acceptance. The percentage of surgical revascularizations performed to correct intermittent claudication varies as a function of patient demographics, surgical results and the prevailing attitudes in a particular institution. According to current clinical series, claudication will progress to limb-threatening ischemia in only a small percentage (-10%) of patients who will require Intervention." Both surgical and catheterbased interventions carry potential risks of short-and longterm morbidity, although overall morbidity associated with surgery for claudication is acceptably low. Surgical or radiological interventions are justified only if they are safe. effective and durable, and if they are performed after the long-term prognosis for both life and limb is considered. 32 Because the complication rate of operative therapy is slightly higher than that of nonsurgical treatment, surgery should not be performed without an adequate trial of nonoperative therapy.
